CJC-1295 (DAC)

5mg · Lyophilized Powder

CJC-1295 with DAC features a Drug Affinity Complex that binds serum albumin, extending the peptide's half-life to approximately 6–8 days and enabling once-weekly administration. This modification produces sustained, elevated GH and IGF-1 levels rather than the pulsatile pattern of the No-DAC variant — a mechanistically distinct approach to GH axis research. Human studies confirm dose-dependent GH/IGF-1 elevation persisting across the dosing interval.

All products sold by JA Performance Peptides are intended strictly for laboratory research purposes and are not approved for human consumption, veterinary use, or therapeutic application. Not for human use.